Results

POINT Biopharma Global Inc.

09/15/2021 | Press release | Distributed by Public on 09/14/2021 06:52

Convergent Therapeutics and Point Biopharma Announce a Collaboration to Evaluate CONV 01-α (Rosopatamab-225Ac) in combination with PNT2002 for Progressive mCRPC